PD-L1 gene promoter methylation represents a potential diagnostic marker in advanced gastric cancer

Gastric cancer is one of the most prevalent malignant tumors worldwide. Immunological checkpoint inhibitors of the programmed death 1 (PD-1)/programmed cell death-ligand 1 (PD-L1) signaling pathway are effective in the treatment of various malignant tumor types, but the potential of such immunothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Dan, Xing, Chengjuan, Cao, Lin, Zhuo, Yuejian, Wu, Tao, Gao, Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956287/
https://www.ncbi.nlm.nih.gov/pubmed/31966052
http://dx.doi.org/10.3892/ol.2019.11221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956287/
https://www.ncbi.nlm.nih.gov/pubmed/31966052
http://dx.doi.org/10.3892/ol.2019.11221

Ejemplares similares